More Press Releases

View Older Stories View Newer Stories

Jun 2, 2025 10:46PM AmphiStar and Kensing Announce Strategic Partnership to Bring Upcycled Biosurfactants to the North American Personal Care Market
Jun 2, 2025 10:40PM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Digimarc Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - DMRC
Jun 2, 2025 10:30PM Arctech celebrates five years of growth in Argentina and reinforces its commitment to the Southern Cone and LATAM
Jun 2, 2025 10:18PM Dome Living, Digital Frontiers, and the Decentralized Future: Insights with Krishen Iyer
Jun 2, 2025 10:22PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages DoubleVerify Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DV
Jun 2, 2025 10:21PM ROSEN, REGARDED INVESTOR COUNSEL, Encourages TechTarget, Inc. Investors to Inquire About Securities Class Action Investigation - TTGT
Jun 2, 2025 10:18PM NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING
Jun 2, 2025 10:16PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ELV
Jun 2, 2025 10:05PM Vietnamese Agri Trade Mission to Iowa
Jun 2, 2025 10:08PM ROSEN, NATIONAL TRIAL COUNSEL, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIVI
Jun 2, 2025 10:07PM FPT and Cymotive Form Strategic Alliance to Advance Automotive Cybersecurity Innovation
Jun 2, 2025 10:06PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Compass Diversified Holdings Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm- CODI
Jun 2, 2025 09:00PM Anime Tokyo Station Launches Official YouTube Channel
Jun 2, 2025 10:01PM CleanTech Cancels and Discontinues Shares for Salaries Agreement
Jun 2, 2025 10:00PM Cheese Confectionery Specialty Store “NEWYORK PERFECT CHEESE”: Pizza or Sweets? A Slightly Luxurious Appetizer-Style New Item: “Perfect Pizza” -- Advance Release at Tokyo Station Store Startin
Jun 2, 2025 09:52PM Rocket Lab Successfully Launches 10th Electron Mission for Multi-Launch Customer BlackSky
Jun 2, 2025 09:47PM Cycling Community Spirit Shines as INEX Club Charity Ride 2025 Wraps Up in Limassol
Jun 2, 2025 09:35PM Translators' Voices: China shares technological achievements with the world for mutual benefit
Jun 2, 2025 09:15PM Clean Air Metals Files Audited Annual Financial Statements for the Year Ended January 31, 2025
Jun 2, 2025 09:05PM Sangfor Backup Platform Powered by Veeam Sets to Deliver Effortless, Enterprise-Grade Data Protection
Jun 2, 2025 09:00PM 2025 ASCO |Oral Presentation: Disitamab Vedotin Achieves Stellar Efficacy as First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Gastric Cancer
Jun 2, 2025 09:00PM ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer
Jun 2, 2025 09:00PM Jenscare released 30-day follow-up results of LuX-Valve Plus TRINITY study and 1-year follow-up results of JensClip TMVr at EuroPCR 2025
Jun 2, 2025 09:00PM 2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors
Jun 2, 2025 09:00PM Sony, SCREEN, and VitroVo to Start Trial Offer of MEA System Capable of Simultaneous Measuring and Recording Data from Approximately 237,000 Electrodes
Jun 2, 2025 09:00PM XellSmart Secures FDA Clearance for Three Phase I INDs of Allogeneic iPSC-Derived Cell Therapies Targeting Major CNS Diseases: Parkinson's Diseases, Spinal Cord Injury and ALS
Jun 2, 2025 09:00PM Univest Securities, LLC Sponsors Japan GO IPO Summit and the CEO Speaks on Shelf Offerings and PIPEs Panel
Jun 2, 2025 08:42PM PesoRama Reports 2025 Financial Results
Jun 2, 2025 08:30PM Besra Gold Inc. Announces Notice of Special Meeting
Jun 2, 2025 08:25PM Bella Sun Luci Goes Global At Gulfood Exposition
Jun 2, 2025 08:23PM PAIG AI Rebrands as Trust3 AI to Lead the Way in Trusted AI Adoption
Jun 2, 2025 08:22PM Extendicare Acquires Nine Long-Term Care Homes from Revera
Jun 2, 2025 08:19PM CIEE BridgeUSA Celebration Tour To Highlight How International Exchange Makes America Safer, Stronger, and More Prosperous
Jun 2, 2025 08:10PM CoTec Holdings Corp. Announces Filing of Amended and Restated Life Offering Document
Jun 2, 2025 10:26AM Core & Main Named to Fortune 500® for First Time
Jun 2, 2025 08:05PM Greenlane Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules
Jun 2, 2025 08:05PM Tortoise Capital Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of May 30, 2025, for TYG and TEAF
Jun 2, 2025 08:05PM WorkJam Brings Next-Gen AI to the Frontline Workforce with Google Cloud
Jun 2, 2025 08:01PM EVA Air to Join IATA's Turbulence Aware Platform Enhancing Flight Safety
Jun 2, 2025 08:01PM Zareef Hamid Analyzes How AI is Redefining Financial Services
Jun 2, 2025 08:00PM Greenberg Traurig Expands Boston Office, Adds 4 New Associates, 1 Patent Agent
Jun 2, 2025 08:00PM Cognizant Recognized as Pega Partner of the Year for Advancing AI-Powered Enterprise Transformation
Jun 2, 2025 07:51PM ATLAS OCEAN VOYAGES LAUNCHES "BUY 2 EXPEDITIONS, GET 1 FREE" OFFER ON EXTENDED JOURNEYS
Jun 2, 2025 07:48PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Eagle Bancorp, Inc. Investors to Inquire About Securities Class Action Investigation - EGBN
Jun 2, 2025 07:40PM MY DR NOW Launches New Clinic in Glendale, Bringing Hassle-Free Healthcare to the Northwest Valley
Jun 2, 2025 07:37PM CW BANCORP Quarterly Cash Dividend
Jun 2, 2025 07:36PM Clarifying ABOG's Mission and the Certification Process
Jun 2, 2025 07:36PM Clarifying ABOG's Mission and the Certification Process
Jun 2, 2025 07:36PM CACI Closes $1.0 Billion Upsized Offering of 6.375% Senior Notes
Jun 2, 2025 07:30PM Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors
View Newer Stories View Older Stories